Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 3
1997 1
1999 3
2000 2
2003 3
2004 2
2005 3
2006 4
2007 5
2008 1
2009 2
2010 3
2011 2
2012 1
2013 3
2014 3
2015 2
2016 5
2017 4
2018 1
2019 3
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 21536617

61 results
Results by year
Filters applied: . Clear all
Page 1
Apparent mineralocorticoid excess: time of manifestation and complications despite treatment.
Knops NB, Monnens LA, Lenders JW, Levtchenko EN. Knops NB, et al. Pediatrics. 2011 Jun;127(6):e1610-4. doi: 10.1542/peds.2010-1928. Epub 2011 May 2. Pediatrics. 2011. PMID: 21536617
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Al-Harbi T, Al-Shaikh A. Al-Harbi T, et al. J Pediatr Endocrinol Metab. 2012;25(11-12):1083-8. doi: 10.1515/jpem-2012-0113. J Pediatr Endocrinol Metab. 2012. PMID: 23329753
[From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids].
Levtchenko EN, Deinum J, Knoers NV, Hermus AR, Monnens LA, Lenders JW. Levtchenko EN, et al. Ned Tijdschr Geneeskd. 2007 Mar 24;151(12):692-4. Ned Tijdschr Geneeskd. 2007. PMID: 17447595 Review. Dutch.
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
Lin-Su K, Zhou P, Arora N, Betensky BP, New MI, Wilson RC. Lin-Su K, et al. J Clin Endocrinol Metab. 2004 May;89(5):2024-7. doi: 10.1210/jc.2003-031268. J Clin Endocrinol Metab. 2004. PMID: 15126515
Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.
Razzaghy-Azar M, Yau M, Khattab A, New MI. Razzaghy-Azar M, et al. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):145-150. doi: 10.1016/j.jsbmb.2016.02.014. Epub 2016 Feb 15. J Steroid Biochem Mol Biol. 2017. PMID: 26892095
Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.
Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunemaître X, Nicod J, Ferrari P. Morineau G, et al. J Am Soc Nephrol. 2006 Nov;17(11):3176-84. doi: 10.1681/ASN.2006060570. Epub 2006 Oct 11. J Am Soc Nephrol. 2006. PMID: 17035606 Free article.
Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB, Stewart PM. Whorwood CB, et al. J Hypertens Suppl. 1996 Dec;14(5):S19-24. J Hypertens Suppl. 1996. PMID: 9120678
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.
Pizzolo F, Friso S, Morandini F, Antoniazzi F, Zaltron C, Udali S, Gandini A, Cavarzere P, Salvagno G, Giorgetti A, Speziali G, Choi SW, Olivieri O. Pizzolo F, et al. J Clin Endocrinol Metab. 2015 Sep;100(9):E1234-41. doi: 10.1210/jc.2015-1760. Epub 2015 Jun 30. J Clin Endocrinol Metab. 2015. PMID: 26126204
Apparent mineralocorticoid excess (AME) syndrome.
Parvez Y, Sayed OE. Parvez Y, et al. Indian Pediatr. 2013 Apr;50(4):416-8. doi: 10.1007/s13312-013-0100-6. Indian Pediatr. 2013. PMID: 23665601 Free article.
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
Atanasov AG, Ignatova ID, Nashev LG, Dick B, Ferrari P, Frey FJ, Odermatt A. Atanasov AG, et al. J Am Soc Nephrol. 2007 Apr;18(4):1262-70. doi: 10.1681/ASN.2006111235. Epub 2007 Feb 21. J Am Soc Nephrol. 2007. PMID: 17314322 Free article.
61 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback